These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 4055160)

  • 41. [Metabolism of deprsolone in man].
    Fehér T; Koref O; Tankó A; Poteczin E; Bodrogi L
    Acta Pharm Hung; 1975 May; 45(3):128-38. PubMed ID: 1130212
    [No Abstract]   [Full Text] [Related]  

  • 42. Prednisolone pharmacokinetics in relation to dose.
    Rose JQ; Jusko WJ; Nickelsen JA; Green OC
    J Pediatr; 1979 Jun; 94(6):1014-5. PubMed ID: 448518
    [No Abstract]   [Full Text] [Related]  

  • 43. A Comparative Analysis of Multipotent Mesenchymal Stromal Cells derived from Different Sources, with a Focus on Neuroregenerative Potential.
    Petrenko Y; Vackova I; Kekulova K; Chudickova M; Koci Z; Turnovcova K; Kupcova Skalnikova H; Vodicka P; Kubinova S
    Sci Rep; 2020 Mar; 10(1):4290. PubMed ID: 32152403
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Methylprednisolone pharmacokinetics after intravenous and oral administration.
    Al-Habet SM; Rogers HJ
    Br J Clin Pharmacol; 1989 Mar; 27(3):285-90. PubMed ID: 2655680
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of food on the absorption and pharmacokinetics of prednisolone from enteric-coated tablets.
    Al-Habet SM; Rogers HJ
    Eur J Clin Pharmacol; 1989; 37(4):423-6. PubMed ID: 2598978
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Pharmacokinetics and pharmacodynamics of prednisolone following extremely high dosage as prednisolone hemisuccinate].
    Rohdewald VP; Rehder J; Möllmann H; Barth J; Derendorf H
    Arzneimittelforschung; 1987 Feb; 37(2):194-8. PubMed ID: 3580023
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Disopyramide concentrations in saliva.
    Aitio ML; Virtanen R; Lammintausta R
    Int J Clin Pharmacol Ther Toxicol; 1982 Feb; 20(2):68-72. PubMed ID: 7061181
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Population pharmacokinetics of prednisolone in children with acute lymphoblastic leukemia.
    Petersen KB; Jusko WJ; Rasmussen M; Schmiegelow K
    Cancer Chemother Pharmacol; 2003 Jun; 51(6):465-73. PubMed ID: 12698270
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Assessment of subtle changes in glucocorticoid negative feedback using prednisolone: comparison of salivary free cortisol and urinary cortisol metabolites as endpoints.
    Jerjes WK; Cleare AJ; Wood PJ; Taylor NF
    Clin Chim Acta; 2006 Feb; 364(1-2):279-86. PubMed ID: 16168400
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prednisolone elimination in human saliva.
    Al-Habet SM; Rogers HJ
    Int J Clin Pharmacol Ther Toxicol; 1985 Sep; 23(9):485-7. PubMed ID: 4055160
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Application of saliva for drug monitoring. An in vivo model for transmembrane transport.
    Haeckel R; Hänecke P
    Eur J Clin Chem Clin Biochem; 1996 Mar; 34(3):171-91. PubMed ID: 8721405
    [TBL] [Abstract][Full Text] [Related]  

  • 52.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 53.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.